β-catenin and Her2/neu expression in rectal cancer: Association with histomorphological response to neoadjuvant therapy and prognosis

International Journal of Colorectal Disease

Volumn 26, Issue 9, 2011, Pages 1127-1134

  Drebber, Uta ^a   Madeja, Martin ^a   Odenthal, Margarete ^a   Wedemeyer, Inga ^a   Mönig, Stefan P ^a   Brabender, Jan ^a   Bollschweiler, Elfriede ^a   Hölscher, Arnulf H ^a   Schneider, Paul M ^b   Dienes, Hans P ^a   Vallböhmer, Daniel ^a  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

catenin; Her2 neu; Neoadjuvant therapy; Prognosis; Rectal cancer; Response prediction

Indexed keywords

BETA CATENIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; FLUOROURACIL;

ADULT; ADVANCED CANCER; ARTICLE; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER SURVIVAL; CHEMORADIOTHERAPY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RECTUM CANCER; SURVIVAL RATE; TUMOR REGRESSION;

BETA CATENIN; CELL MEMBRANE; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; PROGNOSIS; RECEPTOR, ERBB-2; RECTAL NEOPLASMS; REGRESSION ANALYSIS; SURVIVAL ANALYSIS;

EID: 80052298499     PISSN: 01791958     EISSN: 14321262     Source Type: Journal    
DOI: 10.1007/s00384-011-1213-9     Document Type: Article

References (35)

1. JF Bosset G Calais A Daban C Berger L Radosevic-Jelic P Maingon E Bardet M Pierart A Briffaux 2004 Preoperative chemoradiotherapy versus preoperative radiotherapy in rectal cancer patients: assessment of acute toxicity and treatment compliance. Report of the 22921 randomised trial conducted by the EORTC Radiotherapy Group Eur J Cancer 40 219 224 14728936 10.1016/j.ejca.2003. 09.032 1:STN:280:DC%2BD2c%2FivFentg%3D%3D (Pubitemid 38077024)
2. JS Kim H Hur NK Kim YW Kim SY Cho JY Kim BS Min JB Ahn KC Keum H Kim SK Sohn CH Cho 2009 Oncologic outcomes after radical surgery following preoperative chemoradiotherapy for locally advanced lower rectal cancer: abdominoperineal resection versus sphincter-preserving procedure Ann Surg Oncol 16 1266 1273 19224287 10.1245/s10434-009-0338-3
3. BD Minsky 2009 Is preoperative chemoradiotherapy still the treatment of choice for rectal cancer? J Clin Oncol 27 5115 5116 19770369 10.1200/JCO.2009.22.9112
4. LM Pasetto 2005 Preoperative versus postoperative treatment for locally advanced rectal carcinoma Future Oncol 1 209 220 16555993 10.1517/14796694.1.2. 209
5. MS Roh LH Colangelo MJ O'Connell G Yothers M Deutsch CJ Allegra MS Kahlenberg L Baez-Diaz CS Ursiny NJ Petrelli N Wolmark 2009 Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03 J Clin Oncol 27 5124 5130 19770376 10.1200/JCO.2009.22.0467
6. R Sauer H Becker W Hohenberger C Rodel C Wittekind R Fietkau P Martus J Tschmelitsch E Hager CF Hess JH Karstens T Liersch H Schmidberger R Raab 2004 Preoperative versus postoperative chemoradiotherapy for rectal cancer N Engl J Med 351 1731 1740 15496622 10.1056/NEJMoa040694 1:CAS:528:DC%2BD2cXovFSksbo%3D (Pubitemid 39383208)
7. D Sebag-Montefiore RJ Stephens R Steele J Monson R Grieve S Khanna P Quirke J Couture C de Metz AS Myint E Bessell G Griffiths LC Thompson M Parmar 2009 Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial Lancet 373 811 820 19269519 10.1016/S0140-6736(09)60484-0
8. JG Guillem DB Chessin AM Cohen J Shia M Mazumdar W Enker PB Paty MR Weiser D Klimstra L Saltz BD Minsky WD Wong 2005 Long-term oncologic outcome following preoperative combined modality therapy and total mesorectal excision of locally advanced rectal cancer Ann Surg 241 829 836 15849519 10.1097/01.sla.0000161980.46459.96 discussion 836-828 (Pubitemid 40604929)
9. R Rosenberg H Nekarda F Zimmermann K Becker F Lordick H Hofler M Molls JR Siewert 2008 Histopathological response after preoperative radiochemotherapy in rectal carcinoma is associated with improved overall survival J Surg Oncol 97 8 13 18085619 10.1002/jso.20844 1:STN:280:DC%2BD2sjmt1antg%3D%3D
10. K Horisberger RD Hofheinz P Palma AK Volkert S Rothenhoefer F Wenz A Hochhaus S Post F Willeke 2008 Tumor response to neoadjuvant chemoradiation in rectal cancer: predictor for surgical morbidity? Int J Colorectal Dis 23 257 264 18071720 10.1007/s00384-007-0408-6 1:STN:280:DC%2BD1c%2Flt1Whuw%3D%3D
11. ER Fearon B Vogelstein 1990 A genetic model for colorectal tumorigenesis Cell 61 759 767 2188735 10.1016/0092-8674(90)90186-I 1:CAS:528: DyaK3cXktlyhtrg%3D (Pubitemid 20185636)
12. W de Lau N Barker H Clevers 2007 WNT signaling in the normal intestine and colorectal cancer Front Biosci 12 471 491 17127311 10.2741/2076 (Pubitemid 46852800)
13. K Kitisin L Mishra 2006 Molecular biology of colorectal cancer: new targets Semin Oncol 33 S14 S23 17178280 10.1053/j.seminoncol.2006.10.003 1:CAS:528:DC%2BD2sXhsVSntbY%3D (Pubitemid 44908567)
14. VW Yang 1999 The molecular genetics of colorectal cancer Curr Gastroenterol Rep 1 449 454 10980985 10.1007/s11894-999-0028-0 1:STN:280:DC%2BD3M%2FitVOrsA%3D%3D
15. LK Su B Vogelstein KW Kinzler 1993 Association of the APC tumor suppressor protein with catenins Science 262 1734 1737 8259519 10.1126/science.8259519 1:CAS:528:DyaK2cXltFCmtw%3D%3D (Pubitemid 24030097)
16. B Rubinfeld B Souza I Albert O Muller SH Chamberlain FR Masiarz S Munemitsu P Polakis 1993 Association of the APC gene product with beta-catenin Science 262 1731 1734 8259518 10.1126/science.8259518 1:CAS:528: DyaK2cXltFCmtg%3D%3D (Pubitemid 24030096)
17. AM Ochs L Wong V Kakani S Neerukonda J Gorske A Rao M Riggs H Ward L Keville 2004 Expression of vascular endothelial growth factor and HER2/neu in stage II colon cancer and correlation with survival Clin Colorectal Cancer 4 262 267 15555209 10.3816/CCC.2004.n.025 1:CAS:528:DC%2BD2MXhsVyrtg%3D%3D (Pubitemid 40012323)
18. S Kapitanovic S Radosevic M Kapitanovic S Andelinovic Z Ferencic M Tavassoli D Primorac Z Sonicki S Spaventi K Pavelic R Spaventi 1997 The expression of p185(HER-2/neu) correlates with the stage of disease and survival in colorectal cancer Gastroenterology 112 1103 1113 9097992 10.1016/S0016- 5085(97)70120-3 1:STN:280:DyaK2s3lt1ChsQ%3D%3D (Pubitemid 27157520)
19. GJ Tsioulias T Muto Y Morioka T Yamamoto S Mori 1990 erbB-2 gene expression in colorectal cancer Jpn J Exp Med 60 343 349 1982887 1:STN:280:DyaK3M3lvFKqtg%3D%3D
20. J D'Emilia K Bulovas K D'Ercole B Wolf G Steele Jr 1989 Summerhayes IC: expression of the c-erbB-2 gene product (p185) at different stages of neoplastic progression in the colon Oncogene 4 1233 1239 2571966 (Pubitemid 19246968)
21. PM Schneider SE Baldus R Metzger M Kocher R Bongartz E Bollschweiler H Schaefer J Thiele HP Dienes RP Mueller AH Hoelscher 2005 Histomorphologic tumor regression and lymph node metastases determine prognosis following neoadjuvant radiochemotherapy for esophageal cancer: implications for response classification Ann Surg 242 684 692 16244542 10.1097/01.sla.0000186170.38348.7b (Pubitemid 41567124)
22. International Union Against Cancer (UICC) (2002) TNM classification of malignant tumors, 6th edn. Wiley, New York
23. O Dworak L Keilholz A Hoffmann 1997 Pathological features of rectal cancer after preoperative radiochemotherapy Int J Colorectal Dis 12 19 23 9112145 10.1007/s003840050072 1:STN:280:DyaK2s3ms1emsw%3D%3D (Pubitemid 27138353)
24. C Rödel P Martus T Papadoupolos L Fuzesi M Klimpfinger R Fietkau T Liersch W Hohenberger R Raab R Sauer C Wittekind 2005 Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer J Clin Oncol 23 8688 8696 16246976 10.1200/JCO.2005.02.1329 (Pubitemid 46211512)
25. C Jakob T Liersch W Meyer GB Baretton W Schwabe P Hausler B Kulle H Becker DE Aust 2006 Prognostic value of histologic tumor regression, thymidylate synthase, thymidine phosphorylase, and dihydropyrimidine dehydrogenase in rectal cancer UICC Stage II/III after neoadjuvant chemoradiotherapy Am J Surg Pathol 30 1169 1174 16931962 (Pubitemid 44299350)
26. J Lindebjerg KL Spindler J Ploen A Jakobsen 2009 The prognostic value of lymph node metastases and tumour regression grade in rectal cancer patients treated with long-course preoperative chemoradiotherapy Colorectal Dis 11 264 269 18573119 10.1111/j.1463-1318.2008.01599.x 1:STN:280:DC%2BD1M7msFShsQ%3D%3D
27. T Brabletz T Kirchner 2003 Morphogenetic aspects of colorectal cancer Pathologe 24 44 48 12601477 1:STN:280:DC%2BD3s%2FptVSjsA%3D%3D (Pubitemid 36681928)
28. B Savas A Ensari S Percinel I Kuzu MA Kuzu M Bektas H Cetinkaya N Kursun 2007 The significance of beta-catenin, E-cadherin, and P-cadherin expressions in neoplastic progression of colorectal mucosa: an immunohistochemical study Acta Gastroenterol Belg 70 339 344 18330089 (Pubitemid 351251958)
29. K Gunther T Brabletz C Kraus O Dworak MA Reymond A Jung W Hohenberger T Kirchner F Kockerling WG Ballhausen 1998 Predictive value of nuclear beta-catenin expression for the occurrence of distant metastases in rectal cancer Dis Colon Rectum 41 1256 1261 9788389 10.1007/BF02258226 1:STN:280:DyaK1M%2Fgt1Cgug%3D%3D (Pubitemid 28477975)
30. E Fernebro PO Bendahl M Dictor A Persson M Ferno M Nilbert 2004 Immunohistochemical patterns in rectal cancer: application of tissue microarray with prognostic correlations Int J Cancer 111 921 928 15300804 10.1002/ijc.20229 1:CAS:528:DC%2BD2cXntVant7s%3D (Pubitemid 39096241)
31. SE Baldus SP Monig S Huxel S Landsberg FG Hanisch K Engelmann PM Schneider J Thiele AH Holscher HP Dienes 2004 MUC1 and nuclear beta-catenin are coexpressed at the invasion front of colorectal carcinomas and are both correlated with tumor prognosis Clin Cancer Res 10 2790 2796 15102686 10.1158/1078-0432.CCR-03-0163 1:CAS:528:DC%2BD2cXjt1Cltbs%3D (Pubitemid 38509157)
32. JS Ross JA Fletcher 1998 The HER-2/neu oncogene in breast cancer: prognostic factor, predictive factor, and target for therapy Oncologist 3 237 252 10388110
33. TJ Kruser DL Wheeler 2010 Mechanisms of resistance to HER family targeting antibodies Exp Cell Res 316 7 1083 1100 20064507 10.1016/j.yexcr.2010. 01.009 1:CAS:528:DC%2BC3cXksVejtbg%3D
34. AM Kluftinger BW Robinson NF Quenville RJ Finley NL Davis 1992 Correlation of epidermal growth factor receptor and c-erbB2 oncogene product to known prognostic indicators of colorectal cancer Surg Oncol 1 97 105 1285215 10.1016/0960-7404(92)90062-P 1:STN:280:DyaK2c%2FntlCgtw%3D%3D
35. PG Natali MR Nicotra A Bigotti I Venturo DJ Slamon BM Fendly A Ullrich 1990 Expression of the p185 encoded by HER2 oncogene in normal and transformed human tissues Int J Cancer 45 457 461 1968437 10.1002/ijc.2910450314 1:STN:280:DyaK3c7ntVWqsQ%3D%3D (Pubitemid 20087192)